ArticleCardiovascular diabetology2020

Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice.

Enrico Longato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.